August 2018

New Product - Ryzodeg 70/30

Insulin degludec/insulin aspart (rys) (Ryzodeg 70/30) is a soluble insulin analogue product consisting of ultra-long acting basal insulin degludec and rapid acting prandial (mealtime) insulin aspart. Ryzodeg 70/30 can be administered once or twice daily with the main meal(s). When needed, the patient can change the time of administration as long as Ryzodeg 70/30 is dosed with the largest meal when taken once daily. Ryzodeg 70/30 is indicated to improve glycaemic control in adults with diabetes mellitus requiring basal and prandial insulin. Ryzodeg 70/30 FlexTouch solution for injection prefilled multidose disposable pen (containing 3 mL cartridge) is available in pack sizes 1 x 3 mL, 5 x 3 mL. Ryzodeg 70/30 Penfill solution for injection (3 mL cartridge) is available in pack size 5 x 3 mL.

This list is a summary of only some of the changes that have occurred over the last month. Before prescribing, always refer to the full product information.

Copyright © MIMS Australia┬áPty Ltd. All rights reserved.

MIMS Australia
Level 2, 1 Chandos Street
St Leonards NSW 2065
Phone: 1800 800 629
info@mims.com.au
www.mims.com.au